System and methods for use in vision assessment to determine refractive errors and neurodegenerative disorders by ocular biomarking features

12102,387

17/239413

April 23, 2021

A diagnostic device for use in performing refractive errors assessment and neurodegenerative disorders screening is described herein. The diagnostic device includes a display configure to render dynamically adjusted, dichoptic visual stimuli to a user, a varifocal optics system orientated between the display and the user's eyes, an ocular reflex analyzer emitting light signals towards the user's eye s and obtaining light signal reflected from selected part of the eye to measure eye accommodation during an on-going visual stimulation, and an eye tracking system configured to track movement of the user's eyes.

RemmedVR Sp. z o.o. (Warsaw, PL)

RemmedVR Sp. Z.o.o. (Warsaw, PL)

1. A diagnostic device for use in performing refractive errors assessment and neurodegenerative disorders screening, comprising: a display configure to render dynamically adjusted, binocular or dichoptic visual stimuli to a user; a varifocal optics system orientated between the display and the user's eyes, the varifocal optics system including a pair of metalenses, each metalens being associated with a corresponding eye of the user; an ocular reflex analyzer emitting light signals towards the user's eyes and obtaining light signal reflected from selected part of the eye to measure eye accommodation during an on-going visual stimulation; and an eye tracking system configured to track movement of the user's eyes.

2. The diagnostic device of claim 1 , further comprising a processor programmed to performing a neurodegenerative disease screening exam by executing an algorithm including the steps of: adjusting the varifocal optics system to provide an initial refractive error correction; displaying visual stimuli on the display based on desired test procedure; collecting eye movement data using eye tracking system; and determining neurodegenerative disease by comparing collected eye movement data with baseline eye movement data associated with desired test scenario.

3. The diagnostic device of claim 2 , wherein the processor is programmed to perform a refractive errors assessment by executing an algorithm including the steps of: displaying visual stimuli on the display based on desired refractive errors assessment test procedure; collecting eye movement data using eye tracking system; collecting ocular accommodation data using the ocular reflex analyzer; and determining ocular behavior and best refractive correction based on collected eye movement data and ocular behavior data.

4. The diagnostic device of claim 1 , wherein the varifocal optics system includes a first set of metalenses associated with a first eye of the user and a second set of metalenses associated with a second eye of the user, each set of metalenses including at least one tunable metalens.

5. The diagnostic device of claim 1 , wherein the varifocal optics system includes a pair of tunable liquid-membrane lenses, each tunable liquid-membrane lens being associated with a corresponding eye of the user.

6. The diagnostic device of claim 1 , wherein the ocular reflex analyzer includes a projection assembly including a near-infrared (NIR) marker projecting module configured to produce an image marker on both a retina and a cornea of the eye.

7. The diagnostic device of claim 6 , wherein the ocular reflex analyzer includes an acquisition assembly is configured to perform detection of the image marker produced by the projection assembly.

8. The diagnostic device of claim 1 , wherein the ocular reflex analyzer includes: a light emitter configured to emit light to obtain retinal reflex of the user's eye; a sensor configured to receive reflected light from the user's eye and record the retinal reflex of the user's eye; a NIR sensor configured to receive reflected light from the user's eye and record the cornea reflex of the user's eye; a hot mirror configured to reflect the light emitted from the light emitter towards the user's eye and reflect the reflected light from the user's eye towards the sensor; and a varifocal optics for image synthesis of the measurement marker from retina and cornea reflex of the user's eye.

9. The diagnostic device of claim 8 , wherein the ocular reflex analyzer further includes a beam splitter orientated to reflect the light emitted from the light emitter towards the hot mirror and pass the reflected light from the hot mirror towards the sensor.

10. The diagnostic device of claim 1 , wherein the eye tracking system includes a micro-electro-mechanical systems (MEMS) sensor assembly for tracking a position of the user's eyes.

11. The diagnostic device of claim 10 , wherein the MEMS sensor assembly includes: a laser diode for emitting a beam of light; a light detector configured to detect reflected light from the user's eye; and an oscillating micro-mirror configured to reflect the light emitted from the laser diode towards the user's eye and reflect radiation from the user's eye towards the light detector.

12. The diagnostic device of claim 11 , wherein the MEMS sensor assembly further includes a beam splitter orientated to reflect the beam of light from the laser diode towards the oscillating micro-mirror and pass the reflect radiation received from the oscillating micro-mirror towards the light detector.

13. The diagnostic device of claim 10 , wherein the eye tracking system further includes a 2D profile sensor for providing temporal features of eye movements based on retina position.

14. A method of operating a diagnostic device for performing a neurodegenerative disease screening exam, the diagnostic device including a display configure to render dynamically adjusted, binocular or dichoptic visual stimuli to a user, a varifocal optics system orientated between the display and the user's eyes, an eye tracking system configured to track movement of the user's eyes, and a processor, wherein the eye tracking system includes a MEMS sensor assembly for eye movements spatial parameters determination and a 2D profile sensor for eye movements spatial parameters determination, the method including the processor executing the algorithm steps of: adjusting the varifocal optics system to an initial refractive correction; displaying visual stimuli on the display based on desired test procedure; collecting eye movement data using eye tracking system; and determining neurodegenerative disease by comparing collected eye movement data with baseline eye movement data associated with desired test scenario.

15. The method of claim 14 , wherein the processor executes the algorithm step of: adjusting the visual stimuli based on collected eye movement data; collecting subsequent eye movement data in response to adjusted visual stimuli; and determining indication of neurodegenerative disease by comparing collected eye movement data with baseline eye movement data associated with desired test scenario.

16. A method of operating a diagnostic device for performing a refractive errors assessment, the diagnostic device including a display configure to render dynamically adjusted, binocular or dichoptic visual stimuli to a user, a varifocal optics system orientated between the display and the user's eyes, an ocular reflex analyzer emitting light signals towards the user's eye s and obtaining light signal reflected from selected part of the eye to measure eye accommodation during an on-going visual stimulation, an eye tracking system configured to track movement of the user's eyes, and a processor, wherein the eye tracking system includes a MEMS sensor assembly for eye movements spatial parameters determination and a 2D profile sensor for eye movements spatial parameters determination, the method including the processor executing the algorithm steps of: displaying visual stimuli on the display based on desired refractive errors assessment test procedure; collecting eye movement data using eye tracking system; collecting ocular accommodation data using the ocular reflex analyzer; and determining best refractive correction and ocular behavior based on collected eye movement data and ocular behavior data.

17. The method of claim 16 , wherein the processor executes the algorithm step of: adjusting optical conditions and/or visual stimuli; collecting subsequent eye movement data and ocular accommodation data in response to adjusted optical conditions and/or visual stimuli; and determining ocular behavior based on the subsequent eye movement data and ocular accommodation data.

8113655 February 2012 Tyrin et al.
9386921 July 2016 Cleveland
9678345 June 2017 Melzer et al.
9706910 July 2017 Blaha et al.
10248001 April 2019 Lu et al.
10310598 June 2019 Trail et al.
10317672 June 2019 Sarkar
10326977 June 2019 Mercier et al.
10335027 July 2019 Pamplona et al.
10379356 August 2019 Nicholls et al.
10394034 August 2019 Reshidko et al.
10445860 October 2019 Fix et al.
20110157550 June 2011 Chen
20170112667 April 2017 Fateh
20170172406 June 2017 Pamplona et al.
20170293146 October 2017 Nicholls et al.
20170293356 October 2017 Khaderi et al.
20180196509 July 2018 Trail
20180210547 July 2018 Sarkar
20180263488 September 2018 Pamplona et al.
20190050051 February 2019 Cirucci et al.
20190082954 March 2019 Kiderman et al.
20190150727 May 2019 Blaha et al.
20190155046 May 2019 Wall et al.
20190250703 August 2019 Price et al.
20190250704 August 2019 Price et al.
20190290529 September 2019 Park
20210055792 February 2021 Vostrikov
102961117 March 2013
108937840 December 2018
109288493 February 2019
10 2015 217 682 March 2017
2506754 December 2014
10-2018-0083069 July 2018
10-2019-0026651 March 2019
10-2019-0062023 June 2019
M525171 July 2016
2014/055600 April 2014
2017/181010 October 2017
2018/112254 June 2018
2018/203297 November 2018
2018/213010 November 2018
2019/109058 June 2019

URL Only) https://www.youtube.com/watch?v=kAreDffuVCQ. cited by applicant
Robert G. Alexander et al., Microsaccade Characteristics in Neurological and Ophthalmic Disease, Frontiers in Neurology, Mar. 13, 2018, pp. 1-9, vol. 9, Article 144. cited by applicant
Fatimah Zara Javaid et al., Visual and Ocular Manifestations of Alzheimer's Disease and Their Use as Biomarkers for Diagnosis and Progression, Frontiers in Neurology, Apr. 19, 2016, pp. 1-11, vol. 7, Article 55. cited by applicant
CA Antoniades et al., Ocular motor abnormalities in neurodegenerative disorders, Cambridge Ophthalmological Symposium, Eye (2015) 29, 200-207, Macmillan Publishers Limited. cited by applicant
Elliott Hampsey et al., Microsaccade rate as a measure of drug response, Journal of Eye Movement Research, Oct. 3, 2019, pp. 1-20, 12(6):12. cited by applicant
A.B. Sereno et al., Executive Functions: Eye Movements and Human Neurological Disorders, Encyclopedia of Neuroscience, 2009, pp. 117-122, https://doi.org/10.1016/B978-0-12-809324-5.02099-X, ScienceDirect, Elsevier Inc. cited by applicant
Mattias Nilsson Benfatto et al., Screening for Dyslexia Using Eye Tracking during Reading, Journal.pone, Dec. 9, 2016, pp. 1-16, PLoS One. cited by applicant
Ehud Ahissar et al., On the possible roles of microsaccades and drifts in visual perception, ScienceDirect, Vision Research 118 (2016), pp. 25-30, Elsevier Ltd. cited by applicant
J. M. Findlay, Frequency analysis of human involuntary eye movement, Kybernetik 8, Jun. 1971, pp. 207-214, https://link.springer.com/article/10.1007%2FBF00288749#citeas, SpringerLink. cited by applicant
Christoph Klein et al., An Introduction to its Scientific Foundations and Applications, Eye Movement Research, https://link.springer.com/book/10.1007%2F978-3-030-20085-5#about, SpringerLink. cited by applicant
Uzma Samadani et al., Sensitivity and specificity of an eye movement tracking-based biomarker for concussion, Future Science Group, Aug. 6, 2015, pp. 1-14. cited by applicant
Roberto Rodriguez-Labrada et al., Eye Movement Abnormalities in Neurodegenerative Diseases, IntechOpen, Jan. 25, 2019, 17 pages, https://doi.org/10.5772/intechopen.81948. cited by applicant
Kentaro Morita, MD, et al., Eye Movement as a biomarker of schizophreniz: Using an integrated eye movement score, Psychiatry and Clinical Neurosciences, 2017, pp. 104-114, 71, The Authors. cited by applicant
Ilya Obyedkov et al., Saccadic eye movements in different dimensions of schizophrenia and in clinical high-risk state of psychosis, BMC Psychiatry, 2019, pp. 1-10, 19:110, The Authors. cited by applicant
Christy K. Sheehy et al., Fixational microsaccades: A quantitative and objective measure of disability in multiple sclerosis, Multiple Sclerosis Journal, Feb. 7, 2020, 7 pages, https://doi.org/10.1177%2F1352458519894712, SAGE Publications Inc. cited by applicant
Marion Charvin, MD et al., Botulinum Toxin A for Chronic Exertional Compartment Syndrome, a Retrospective Study of 16 Upper- and Lower-Limb Cases, Clinical Journal of Sports Medicine, Jul. 16, 2021, 4 pages, https://doi.org/10.1097/JSM.0000000000000731. cited by applicant
Rebecca S. Braveman, MD, Introduction to Amblyopia, America Academy of Ophthalmology, Oct. 21, 2015, 3 pages, https://www.aao.org/disease-review/amblyopia-introduction. cited by applicant
https://www.hamamatsu.com/eu/en/product/type/S13989-01H/index.html. cited by applicant
Neil Sarkar (AdHawk Microsystems): Ultra-Fast Eye Tracking Without Cameras for Mobile AR Headsets, https://www.slideshare.net/AugmentedWorldExpo/neil-sarkar-adhawk-microsystems-ultrafast-eye-tracking-without-cameras-for-mobile-ar-headsets. cited by applicant
Joon-Suh Park et al., All-Glass, Large Metalens at Visible Wavelength Using Deep-Ultraviolet Projection Lithography, ACS Publications, Nov. 14, 2019, pp. 8673-8682, 19, 12, American Chemical Society, https://pubs.acs.org/doi/10.1021/acs.nanolett.9b03333. cited by applicant
Alan She et al., Adaptive metalenses with simultaneous electrical control of focal length, astigmatism, and shift, Science Advances, Feb. 23, 2018, pp. 1-7, The Authors. cited by applicant
Zhenyu Yang et al., Generalized Hartmann-Shack array of dielectric metalens sub-arrays for polarimetric beam profiling, Nature Communications, 2018, pp. 1-7, 9:4607, The Authors. cited by applicant

edspgr.12102387